Living DonorsTissue DonorsUnrelated DonorsTransplantation, HomologousTransplantation, AutologousKidney TransplantationLiver TransplantationHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation ConditioningHistocompatibility TestingDirected Tissue DonationGraft SurvivalHistocompatibilityGraft vs Host DiseaseTissue and Organ ProcurementSiblingsGraft RejectionHematologic NeoplasmsTreatment OutcomeCadaverHeart TransplantationHLA AntigensStem Cell TransplantationLung TransplantationImmunosuppressive AgentsRetrospective StudiesSurvival AnalysisRecurrenceOrgan TransplantationSurvival RateBlood DonorsTime FactorsBlood Transfusion, AutologousCell TransplantationPancreas TransplantationIslets of Langerhans TransplantationTransplantation ImmunologyTransplantationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationTransplantation, IsogeneicCord Blood Stem Cell TransplantationTransplantation, HeterotopicHeart-Lung TransplantationImmunosuppressionTransplantation ToleranceCombined Modality TherapyWhole-Body IrradiationSkin TransplantationLiver FailurePostoperative ComplicationsFetal Tissue TransplantationFollow-Up StudiesMesenchymal Stem Cell TransplantationTissue TransplantationTransplantation, HeterologousMelphalanCorneal TransplantationWaiting ListsT-LymphocytesCyclophosphamideRemission InductionMultiple MyelomaBusulfanCyclosporineTacrolimusTissue and Organ HarvestingLymphoma, Non-HodgkinOrgan PreservationAntineoplastic Combined Chemotherapy ProtocolsLeukemiaHematopoietic Stem CellsTransplantsBone Marrow PurgingHematopoietic Stem Cell MobilizationDisease-Free SurvivalCells, CulturedLiver DiseasesBrain Tissue TransplantationCarmustineAntigens, CD34Myeloablative AgonistsAcute DiseaseSalvage TherapyAntilymphocyte SerumFacial TransplantationRisk FactorsBrain DeathLymphocyte Culture Test, MixedDonor SelectionPrognosisBone Marrow CellsProspective StudiesHodgkin DiseaseAnemia, AplasticMice, Inbred C57BLLymphocyte ActivationLeukemia, Myeloid, AcuteKidney Failure, Chronic